Legal Opinion
Silverstrand Investments v. Amag Pharmaceuticals, Inc.
Court of Appeals for the First Circuit
Decided February 4, 2013No. 11-2063PublishedCited by 90 opinions
1Opinion of the Court
TORRUELLA, Circuit Judge.
This appeal arises from a pleading-stage dismissal of a putative class action suit brought under sections 11, 12, and 15 of the Securities Act of 1933, 15 U.S.C. §§ 77k, 77i(a)(2), 77o. Lead plaintiffs Sil-verstrand Investments, Safron Capital Corporation, and Briarwood Investments (collectively, “Plaintiffs”) challenge the dismissal, arguing that the Complaint plausibly pleads actionable omissions from a prospectus and a registration statement (the “Offering Documents”) issued by AMAG Pharmaceutical, Inc. (“AMAG”) in connection with a secondary stock offering held on…
2Cases cited26 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Foman v. DavisSupreme Court of the United States · 1962
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
- United States v. Ilario M.A. ZanninoCourt of Appeals for the First Circuit · 1990
- Ocasio-Hernandez v. Fortuno-BursetCourt of Appeals for the First Circuit · 2011
21 more not listed; retrieve them via the Exa API.
3Cited by90 opinions
- Stratte-McClure v. StanleyCourt of Appeals for the Second Circuit · 2015
- United States Ex Rel. Ge v. Takeda Pharmaceutical Co.Court of Appeals for the First Circuit · 2013
- Evergreen Partnering Group v. Pactiv CorporationCourt of Appeals for the First Circuit · 2013
- Jaroslawicz v. M&T Bank CorpCourt of Appeals for the Third Circuit · 2020
- Yan v. ReWalk Robotics Ltd.Court of Appeals for the First Circuit · 2020
85 more not listed; retrieve them via the Exa API.